AstraZeneca's booth is seen during an expo in Beijing in November. The pharma company announced an investment of $2.5 billion to establish a global R&D center in Beijing. CHINA DAILY Multinational ...

Tattoos are a universal art form used as a form of self-expression and tribute and as the world’s most tattooed nation, it's no surprise we’re spoilt for choice when it comes to choosing a tattoo ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. A doctor, using a laser, removes tattoos from an ...

MORE: Man deported under Alien Enemies Act because of soccer logo tattoo: Attorney When asked by ABC News about how authorities are determining if migrants are gang members, White House Press ...

As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer (NSCLC), the British pharma has rolled out early data from a trial ...

Speaking to the Commons business and trade select committee on Tuesday, AstraZeneca’s chairman Shaun Grady confirmed that delays in securing a £90 million government contribution led to the collapse ...

In reality, immigration officials appear to be simply detaining any Latino men with tattoos. “The men sent to do hard labor in a Salvadoran prison with no due process include: A tattoo artist ...

“I’m excited and grateful for the opportunity to be part of this brand’s iconic campaign," the Grammy winner said of working with Calvin Klein in his native Puerto Rico Directed and ...

AstraZeneca will leverage Alteogen’s platform technology to develop the therapies. Credit: © AstraZeneca 2025. AstraZeneca has entered an exclusive licence ...

Image credit: Kateryna Kon / Shutterstock. UK-based AstraZeneca’s acquired rare disease drug has met the primary endpoint in a Phase III trial in patients with chronic hypoparathyroidism. The Calypso ...

Monday was a busy day for AstraZeneca, which also paid up to $1 billion to acquire Belgian biotech EsoBiotec and its cell therapy pipeline and technology. AstraZeneca capped off a hectic Monday with a ...

AstraZeneca is buying EsoBiotec for up to $1 billion for the company’s in vivo CAR-T cell drugs, or therapies that reprogram immune cells directly within patients' bodies. Analysts say the deal ...